The Risk of Coronary Heart Disease Associated With Glycosylated Hemoglobin ≥ 6.5% is Pronounced in the Haptoglobin 2-2 Genotype

Por Cahill, Leah E, Jensen, Majken K, Chiuve, Stephanie E, Shalom, Hadar, Pai, Jennifer K, Flint, Alan J, Mukamal, Kenneth J, Rexrode, Kathryn M, Levy, Andrew P, Rimm, Eric B
Publicado no J Am Coll Cardiol (2015)

Pharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability

Por Veiner, Hilla-Lee, Gorbatov, Rostic, Vardi, Moshe, Doros, Gheorghe, Miller-Lotan, Rachel, Zohar, Yaniv, Sabo, Edmond, Asleh, Rabea, Levy, Nina S., Goldfarb, Levi J., Berk, Thomas A., Haas, Tali, Shalom, Hadar, Suss-Toby, Edith, Kam, Adi, Kaplan, Marielle, Tamir, Ronit, Ziskind, Anna, Levy, Andrew P.
Publicado no Atherosclerosis (2015)